Literature DB >> 16021628

Cytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II-induced activation of the SHP-2 tyrosine phosphatase.

Karl Fernstrom1, Paul Farmer, M Showkat Ali.   

Abstract

Angiotensin II is an octapeptide that regulates diverse cellular responses including the actin cytoskeletal organization. In this study, stable cell lines overexpressing wild-type or catalytically inactive SHP-2 were employed to elucidate the signaling pathway utilized by the SHP-2 tyrosine phosphatase that mediates an angiotensin II-induced reorganization of the actin cytoskeleton in vascular smooth muscle cells (VSMC). The expression of wild-type SHP-2 prevented an angiotensin II dependent increase in stress fiber formation. In contrast, the catalytically inactive mutant SHP-2 increased stress fiber formation. Additional observations further established that SHP-2 regulates the reorganization of the actin cytoskeleton through RhoA- and Vav2-dependent signaling pathways. The expression of wild-type SHP-2 caused a dephosphorylation of several focal adhesion associated proteins including paxillin, p130Cas, and tensin in VSMC. This dephosphorylation of focal adhesion associated proteins was accompanied by significantly decreased numbers of focal adhesions within cells. These results demonstrate a unique role for SHP-2 in the regulation of the cellular architecture of VSMC, suggesting the possibility that this phosphatase might be instrumental in vascular remodeling. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16021628     DOI: 10.1002/jcp.20436

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes.

Authors:  Vitaliy Starosta; Konrad Pazdrak; Istvan Boldogh; Tetyana Svider; Alexander Kurosky
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.

Authors:  Fatiha Tabet; Ernesto L Schiffrin; Glaucia E Callera; Ying He; Guoying Yao; Arne Ostman; Kai Kappert; Nicholas K Tonks; Rhian M Touyz
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

3.  Increased vascular smooth muscle cell stiffness: a novel mechanism for aortic stiffness in hypertension.

Authors:  Nancy L Sehgel; Yi Zhu; Zhe Sun; Jerome P Trzeciakowski; Zhongkui Hong; William C Hunter; Dorothy E Vatner; Gerald A Meininger; Stephen F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-24       Impact factor: 4.733

Review 4.  p130 Crk-associated substrate (CAS) in vascular smooth muscle.

Authors:  Dale D Tang
Journal:  J Cardiovasc Pharmacol Ther       Date:  2009-03-27       Impact factor: 2.457

5.  Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration.

Authors:  Teruo Hidaka; Yusuke Suzuki; Michifumi Yamashita; Terumi Shibata; Yuichi Tanaka; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

6.  Cyclophilin A is required for angiotensin II-induced p47phox translocation to caveolae in vascular smooth muscle cells.

Authors:  Nwe Nwe Soe; Mark Sowden; Padmamalini Baskaran; Elaine M Smolock; Yeonghwan Kim; Patrizia Nigro; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-11       Impact factor: 8.311

7.  Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells.

Authors:  Jiao-Hui Wu; Alexander C Fanaroff; Krishn C Sharma; Liisa S Smith; Leigh Brian; Betty A Eipper; Richard E Mains; Neil J Freedman; Lisheng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.